120 related articles for article (PubMed ID: 18974116)
21. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells.
Shih YP; Takada Y; Lo SH
Mol Cancer Res; 2012 Jan; 10(1):34-9. PubMed ID: 22064653
[TBL] [Abstract][Full Text] [Related]
22. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
Ip CK; Cheung AN; Ngan HY; Wong AS
Oncogene; 2011 May; 30(21):2420-32. PubMed ID: 21258406
[TBL] [Abstract][Full Text] [Related]
23. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
[TBL] [Abstract][Full Text] [Related]
24. Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells.
den Hollander P; Kumar R
Cancer Res; 2006 Jun; 66(11):5941-9. PubMed ID: 16740735
[TBL] [Abstract][Full Text] [Related]
25. Coordinate control of proliferation and migration by the p27Kip1/cyclin-dependent kinase/retinoblastoma pathway in vascular smooth muscle cells and fibroblasts.
Díez-Juan A; Andrés V
Circ Res; 2003 Mar; 92(4):402-10. PubMed ID: 12600894
[TBL] [Abstract][Full Text] [Related]
26. Growth factor induced activation of Rho and Rac GTPases and actin cytoskeletal reorganization in human lens epithelial cells.
Maddala R; Reddy VN; Epstein DL; Rao V
Mol Vis; 2003 Jul; 9():329-36. PubMed ID: 12876554
[TBL] [Abstract][Full Text] [Related]
27. DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.
Hewitt C; Wilson P; McGlinn E; MacFarlane G; Papageorgiou A; Woodwards RT; Sloan P; Gollin SM; Paterson I; Parkinson KK; Read AP; Thakker N
Cancer Lett; 2004 Jun; 209(2):207-13. PubMed ID: 15159023
[TBL] [Abstract][Full Text] [Related]
28. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
30. Rho regulation: DLC proteins in space and time.
Braun AC; Olayioye MA
Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
[TBL] [Abstract][Full Text] [Related]
31. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
[TBL] [Abstract][Full Text] [Related]
32. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma.
Ching YP; Wong CM; Chan SF; Leung TH; Ng DC; Jin DY; Ng IO
J Biol Chem; 2003 Mar; 278(12):10824-30. PubMed ID: 12531887
[TBL] [Abstract][Full Text] [Related]
33. ZRP-1 controls Rho GTPase-mediated actin reorganization by localizing at cell-matrix and cell-cell adhesions.
Bai CY; Ohsugi M; Abe Y; Yamamoto T
J Cell Sci; 2007 Aug; 120(Pt 16):2828-37. PubMed ID: 17652164
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line.
Jin Y; Tian X; Shang Y; Huang P
Oncol Rep; 2008 Mar; 19(3):669-74. PubMed ID: 18288400
[TBL] [Abstract][Full Text] [Related]
35. The intracellular stability of DLC1 is regulated by the 26S proteasome in human hepatocellular carcinoma cell line Hep3B.
Luo HW; Luo QP; Yuan Y; Zhu XY; Huang SF; Peng Z; Li CL; Huang ZG; Feng WL
Biochem Biophys Res Commun; 2011 Jan; 404(1):279-83. PubMed ID: 21130076
[TBL] [Abstract][Full Text] [Related]
36. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
[TBL] [Abstract][Full Text] [Related]
37. MEGAP impedes cell migration via regulating actin and microtubule dynamics and focal complex formation.
Yang Y; Marcello M; Endris V; Saffrich R; Fischer R; Trendelenburg MF; Sprengel R; Rappold G
Exp Cell Res; 2006 Jul; 312(12):2379-93. PubMed ID: 16730001
[TBL] [Abstract][Full Text] [Related]
38. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
39. DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration.
Lin Y; Chen NT; Shih YP; Liao YC; Xue L; Lo SH
Oncogene; 2010 May; 29(20):3010-6. PubMed ID: 20208559
[TBL] [Abstract][Full Text] [Related]
40. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration.
Ortíz-López L; Morales-Mulia S; Ramírez-Rodríguez G; Benítez-King G
J Pineal Res; 2009 Jan; 46(1):15-21. PubMed ID: 18482340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
